Mindfulness + Vagal Nerve Stimulation for Alcoholism

This trial explores a new method to help young adults reduce alcohol intake using mindfulness and a device that may stimulate certain nerves to manage stress. Participants will receive a Brief Mindfulness-Based Intervention and use a device that either provides gentle nerve stimulation (Active RAVANS, a vagal nerve stimulation device) or no stimulation. The trial aims to assess how these methods affect heart rate, stress levels, and drinking habits. It is suitable for young adults in Massachusetts who drink heavily, such as consuming more than 14 drinks a week or 5 drinks in one day. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could lead to new ways of managing alcohol consumption and stress.

If you are currently taking medications for alcohol use disorder or sedatives, hypnotics, opioids, or anesthetics, you cannot participate in this trial. The protocol does not specify other medication restrictions.

Research has shown that auricular transcutaneous vagus nerve stimulation (taVNS) is generally safe. Studies have found it helps reduce withdrawal symptoms in people with alcohol use disorder. In a study with 40 participants, taVNS caused no major side effects and was well-tolerated. Some participants experienced mild side effects like skin tingling, but these were not serious.

For the mindfulness-based intervention, research results are mixed. Some studies suggest it helps reduce stress and substance use. However, no strong evidence indicates serious side effects from mindfulness practices. It is generally considered safe and might support other treatments.

Researchers are excited about combining mindfulness with vagal nerve stimulation for treating alcoholism because it offers a novel approach that differs significantly from traditional methods like medications (such as disulfiram or naltrexone) and behavioral therapies. The unique feature of this treatment is the use of a RAVANS device that delivers non-invasive, transcutaneous auricular vagal nerve stimulation (taVNS) specifically during exhalation, which is believed to enhance the calming effects of mindful breathing. This method not only aims to reduce alcohol cravings by stimulating the vagus nerve but also potentially improves emotional regulation and stress management, which are critical components in overcoming addiction. By integrating mindfulness practices with a physiological intervention, this approach could offer a more holistic and effective treatment for individuals struggling with alcoholism.

This trial will compare two approaches for treating alcohol use disorder (AUD): the active RAVANS device and a Brief Mindfulness-Based Intervention. Research has shown that stimulating the vagal nerve, as with the active RAVANS device, can ease withdrawal symptoms and boost mood in people with AUD. It might also reduce anxiety and depression, common in those dealing with alcohol dependence. Some studies suggest it can improve sleep and help manage cravings.